Adherence to antiretroviral therapy (ART) and disclosure of HIV status are critical for achieving HIV viral suppression and eliminating perinatal transmission of HIV.The ENHANCED-SPS intervention was designed to address barriers to viral suppression among pregnant and postpartum women with HIV and included standardized support and counseling though phone calls by peer-mothers. Using targeted minimum loss-based estimation (TMLE), we evaluated changes in adherence (≤1 dose of ART missed per month) and HIV status disclosure (to anyone and to a spouse or partner) among 505 pregnant and postpartum women with HIV who received the ENHANCED-SPSinterventioninruralUganda(2019-2021).ARTadherencewas68%(95%CI,62-74)atbaselineandincreasedto93%(95% CI, 81-100) after 12 months, corresponding to a 25% increase (95% CI, 9-40; P = .009). Largest improvements were among participants who were aged 15-24 years, breastfeeding, or without viral suppression at enrollment. At baseline, 80% (95% CI, 69-90) had disclosed their HIV status to anyone—increasing to 94% (95% CI, 89-99) after 12 months and corresponding to a 14% improvement (95% CI, 8-21; P =.003).Similar trends were observed for disclosure to a spouse or partner.Among pregnant and postpartum womenwithHIVinrural Uganda,the ENHANCED-SPS intervention was associated with meaningful improvements in ART adherence and HIV status disclosure after 1 year.
Abstract:
Publication date:
May 15, 2025
Publication type:
Journal Article